Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 3Completed 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Observational 4Interventional 1

Sponsor

Cancer Type

Breast 4Genitourinary 1

Conditions

Breast Neoplasms 2Breast Cancer Patients 2Prostatic Neoplasms 1Chronic Pain 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Polymorphism, Single Nucleotide × Clear all
NCT05507034 2023-12-27

sCANsens

Universiteit Antwerpen

Unknown
150 enrolled
Breast

Breast Neoplasms, Chronic Pain

NCT01739062 2023-12-04

ProCaRis

University of Aarhus

Phase NA Active not recruiting
5,000 enrolled
Genitourinary

Prostatic Neoplasms

NCT04654195 2020-12-04

Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient

Damanhour University

Unknown
100 enrolled
Breast

Breast Cancer Patients

NCT04581967 2020-10-09

Study of CYP2C19 and ALDH3A1 Polymorphisms in Breast Cancer Patients

Damanhour University

Unknown
100 enrolled
Breast

Breast Cancer Patients

NCT00283608 2011-05-16

Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Stage I, Stage II, or Stage III Breast Cancer

Mayo Clinic

Completed
1,000 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡